Dexmedetomidine Baxter 200 μg/2 ml
Dexmedetomidine Baxter 200 μg/2 ml is a medicine authorised by Swissmedic under authorisation number 68249. The authorisation holder is Baxter AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 October 2022 and the authorisation is limited until 25 October 2027. ATC code N05CM18 places the medicine in the group Psycholeptics.
| Authorisation number | 68249 |
|---|---|
| Name | Dexmedetomidine Baxter 200 μg/2 ml |
| Full name | Dexmedetomidine Baxter 200 μg/2 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Baxter AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | N05CM18 |
| First authorisation | 26 October 2022 |
| Authorisation validity | 25 October 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dexmedetomidine Baxter 200 μg/2 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 26 October 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Durchstechflasche(n) | N05CM18 | 01.04.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dexmedetomidine Baxter 200 μg/2 ml authorised in Switzerland?
Yes. Dexmedetomidine Baxter 200 μg/2 ml is authorised by Swissmedic under authorisation number 68249, data as of 01 September 2026. The authorisation is limited until 25 October 2027.
Which dispensing category does Dexmedetomidine Baxter 200 μg/2 ml have?
Dexmedetomidine Baxter 200 μg/2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Dexmedetomidine Baxter 200 μg/2 ml?
The authorisation holder is Baxter AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.